R. White William's Insider Trades & SAST Disclosures
R. White William's most recent trade in Akero Therapeutics Inc was a trade of 676 Common Stock done at an average price of $44.9 . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. White William.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.88 per share. | 12 Mar 2025 | 676 | 61,959 (0%) | 0% | 44.9 | 30,339 | Common Stock |
| Akero Therapeutics Inc | William White R. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 73,700 | 73,700 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | R. William White | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 24,300 | 62,635 (0%) | 0% | 0 | Common Stock | |
| Akero Therapeutics Inc | White William R. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.79 per share. | 10 Dec 2024 | 2,817 | 38,335 (0%) | 0% | 30.8 | 86,735 | Common Stock |
| Disc Medicine Inc | R. William White | Director | Sale of securities on an exchange or to another person at price $ 64.58 per share. | 02 Dec 2024 | 1,762 | 173 | - | 64.6 | 113,790 | Common Stock |
| Disc Medicine Inc | White William R. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 1,756 | 0 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William White R. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 02 Dec 2024 | 1,756 | 1,756 | - | 2.6 | 4,653 | Common Stock |
| Disc Medicine Inc | White R. William | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 201 | 1,804 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | R. William White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 02 Dec 2024 | 201 | 1,957 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 65.34 per share. | 02 Dec 2024 | 173 | 0 | - | 65.3 | 11,303 | Common Stock |
| Disc Medicine Inc | R. White William | Director | Sale of securities on an exchange or to another person at price $ 63.50 per share. | 02 Dec 2024 | 22 | 1,935 | - | 63.5 | 1,397 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 7,136 | 0 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.69 per share. | 01 Nov 2024 | 7,136 | 7,136 | - | 45.7 | 326,044 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 58.94 per share. | 01 Nov 2024 | 5,346 | 0 | - | 58.9 | 315,118 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 57.59 per share. | 01 Nov 2024 | 1,790 | 5,346 | - | 57.6 | 103,089 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 01 Nov 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 201 | 2,005 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 46.74 per share. | 01 Nov 2024 | 129 | 0 | - | 46.7 | 6,030 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 45.68 per share. | 01 Nov 2024 | 72 | 129 | - | 45.7 | 3,289 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 01 Oct 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 201 | 2,206 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 52.53 per share. | 01 Oct 2024 | 79 | 0 | - | 52.5 | 4,150 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 01 Oct 2024 | 50 | 79 | - | 51.5 | 2,576 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 50.45 per share. | 01 Oct 2024 | 40 | 129 | - | 50.5 | 2,018 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 49.03 per share. | 01 Oct 2024 | 32 | 169 | - | 49.0 | 1,569 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.18 per share. | 10 Sep 2024 | 639 | 41,152 (0%) | 0% | 26.2 | 16,729 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 1,756 | 1,756 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 03 Sep 2024 | 1,756 | 1,957 | - | 2.6 | 4,653 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 49.43 per share. | 03 Sep 2024 | 1,560 | 397 | - | 49.4 | 77,111 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 50.29 per share. | 03 Sep 2024 | 337 | 60 | - | 50.3 | 16,947 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 03 Sep 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 201 | 2,407 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 51.54 per share. | 03 Sep 2024 | 50 | 10 | - | 51.5 | 2,577 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 52.30 per share. | 03 Sep 2024 | 10 | 0 | - | 52.3 | 523 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 26 Aug 2024 | 32,671 | 74,462 (0%) | 0% | 7.0 | 228,991 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 32,671 | 0 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 26 Aug 2024 | 32,671 | 41,791 (0%) | 0% | 27.2 | 889,011 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 24,372 | 116,833 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 26 Aug 2024 | 24,372 | 41,791 (0%) | 0% | 27.2 | 663,186 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.87 per share. | 26 Aug 2024 | 24,372 | 66,163 (0%) | 0% | 19.9 | 484,272 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 23,175 | 24,745 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.41 per share. | 26 Aug 2024 | 23,175 | 41,791 (0%) | 0% | 26.4 | 612,098 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.09 per share. | 26 Aug 2024 | 23,175 | 64,966 (0%) | 0% | 21.1 | 488,761 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 18,116 | 47,920 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 26 Aug 2024 | 18,116 | 41,791 (0%) | 0% | 27.2 | 492,954 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.09 per share. | 26 Aug 2024 | 18,116 | 59,907 (0%) | 0% | 21.1 | 382,066 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 201 | 2,608 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 01 Aug 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 43.24 per share. | 01 Aug 2024 | 144 | 57 | - | 43.2 | 6,226 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 43.95 per share. | 01 Aug 2024 | 57 | 0 | - | 43.9 | 2,505 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 139,083 | 54,943 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 23 Jul 2024 | 139,083 | 180,874 (0%) | 0% | 7.0 | 974,833 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 23 Jul 2024 | 79,446 | 41,791 (0%) | 0% | 27.2 | 2,160,137 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.71 per share. | 23 Jul 2024 | 59,637 | 121,237 (0%) | 0% | 26.7 | 1,592,904 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 23 Jul 2024 | 22,272 | 64,063 (0%) | 0% | 7.0 | 156,104 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 22,272 | 32,671 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.66 per share. | 23 Jul 2024 | 20,481 | 41,791 (0%) | 0% | 27.7 | 566,463 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 23 Jul 2024 | 1,791 | 62,272 (0%) | 0% | 27 | 48,357 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 500 | 194,026 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 23 Jul 2024 | 500 | 41,791 (0%) | 0% | 28.0 | 14,005 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 23 Jul 2024 | 500 | 42,291 (0%) | 0% | 7.0 | 3,505 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 29,803 | 194,526 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 16 Jul 2024 | 29,803 | 46,799 (0%) | 0% | 28.0 | 835,825 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.01 per share. | 16 Jul 2024 | 29,803 | 76,602 (0%) | 0% | 7.0 | 208,889 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 16 Jul 2024 | 5,008 | 41,791 (0%) | 0% | 28.0 | 140,449 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 01 Jul 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 201 | 2,809 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 45.92 per share. | 01 Jul 2024 | 109 | 74 | - | 45.9 | 5,005 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 46.45 per share. | 01 Jul 2024 | 74 | 0 | - | 46.4 | 3,437 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Jul 2024 | 18 | 183 | - | 45.1 | 811 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.64 per share. | 11 Jun 2024 | 2,831 | 46,799 (0%) | 0% | 22.6 | 64,094 | Common Stock |
| Ventyx Biosciences Inc | William R. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 03 Jun 2024 | 1,756 | 1,756 | - | 2.6 | 4,653 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 1,756 | 3,512 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 36.10 per share. | 03 Jun 2024 | 1,755 | 95 | - | 36.1 | 63,359 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 201 | 3,010 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 03 Jun 2024 | 201 | 1,957 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 35.15 per share. | 03 Jun 2024 | 107 | 1,850 | - | 35.1 | 3,761 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 36.72 per share. | 03 Jun 2024 | 95 | 0 | - | 36.7 | 3,488 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 201 | 3,211 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 01 May 2024 | 201 | 201 | - | 9.9 | 1,982 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 28.51 per share. | 01 May 2024 | 162 | 39 | - | 28.5 | 4,619 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 29.10 per share. | 01 May 2024 | 39 | 0 | - | 29.1 | 1,135 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 11 Apr 2024 | 2,482 | 78 | - | 31.8 | 78,897 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 1,756 | 5,268 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 11 Apr 2024 | 1,756 | 1,756 | - | 2.6 | 4,653 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 804 | 3,412 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 11 Apr 2024 | 804 | 2,560 | - | 9.9 | 7,927 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Sale of securities on an exchange or to another person at price $ 32.18 per share. | 11 Apr 2024 | 78 | 0 | - | 32.2 | 2,510 | Common Stock |
| Akero Therapeutics Inc | William R. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.33 per share. | 13 Mar 2024 | 724 | 49,630 (0%) | 0% | 28.3 | 20,511 | Common Stock |
| Ventyx Biosciences Inc | R. White William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Akero Therapeutics Inc | William White R. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 14 Dec 2023 | 611 | 50,354 (0%) | 0% | 20.8 | 12,684 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 21,084 | 7,024 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | White R. William | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 12 Dec 2023 | 21,084 | 21,084 | - | 2.7 | 55,873 | Common Stock |
| Disc Medicine Inc | White William R. | Director | Sale of securities on an exchange or to another person at price $ 65.26 per share. | 12 Dec 2023 | 16,263 | 4,057 | - | 65.3 | 1,061,341 | Common Stock |
| Disc Medicine Inc | White William R. | Director | Sale of securities on an exchange or to another person at price $ 59.44 per share. | 12 Dec 2023 | 12,100 | 21,411 | - | 59.4 | 719,214 | Common Stock |
| Disc Medicine Inc | William R. White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 7,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | R. William White | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.50 per share. | 12 Dec 2023 | 7,000 | 33,511 | - | 13.5 | 94,500 | Common Stock |
| Disc Medicine Inc | William White R. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 12 Dec 2023 | 5,427 | 26,511 | - | 9.9 | 53,510 | Common Stock |
| Disc Medicine Inc | R. White William | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 5,427 | 4,216 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges